Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

multiplemyelomahub.com - This article focuses on the addition of mAbs to standard triplet regimens as frontline treatment for newly diagnosed MM (NDMM), and their latest clinical...

ASCO Educational Book - ...

OncLive - Solange Peters, MD, discusses the promising clinical activity observed with trastuzumab deruxtecan in patients with HER2-mutated NSCLC, next steps for research, and other exciting...

Members in Training

posted 12 hours

Shared 2 times

American Society of Clinical Oncology - Membership in ASCO is essential for every early-career oncologist. Physicians enrolled in an oncology subspecialty training program gain access to the complete portfolio of...

www.gotoper.com - Optimizing Outcomes in Prostate Cancer: Matching Treatment...

know.lww.com - Findings from a phase III study showed that cediranib plus olaparib had similar activity to standard platinum-based chemotherapy in relapsed platinum-sensitive ovarian cancer, according...

OncLive - The FDA has granted priority review to a new supplemental biologics license application for pembrolizumab monotherapy as a treatment for adult patients with relapsed/refractory...

ASCO Post - Benefit Seen Solely in Selected Patients Treated at Specialized Centers By Alice Goodman Posted: 7/8/2020 2:12:00 PM Last Updated: 7/8/2020 2:45:12 PM Two phase...

OncLive - Benjamin Weinberg, MD, shares the clinical implications of how data from the 2020 ASCO Virtual Scientific Program may impact in the treatment of patients...